SiVEC Biotechnologies’ delivery platform enables tissue-specific delivery of biologically active molecular cargo.
For an overview of our work, people, and goals, watch our latest overview video.
BIOLOGICAL PLATFORM FOR NUCLEIC ACID, VACCINE, AND GENE EDITING DELIVERY
SiVEC’s delivery platform uses non-pathogenic bacteria for targeted intracellular delivery of nucleic acid drugs and vaccines to mucosal epithelial cells. SiVEC is seeking to partner with companies who can benefit from using this delivery platform to make their drug or vaccine more efficacious.